Swayampakula Ramakanth Analyst PerformanceManaging Directo at HC WainwrightSwayampakula Ramakanth is a stock analyst at HC Wainwright focused in the medical sector, covering 78 publicly traded companies. Over the past year, Swayampakula Ramakanth has issued 108 stock ratings, including strong buy, buy, and hold recommendations. While full access to Swayampakula Ramakanth's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Swayampakula Ramakanth's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings460 Last 11 YearsBuy Recommendations94.54% 433 Buy RatingsCompanies Covered78 Unique Companies Ratings Distribution458RatingsDistribution of strong buy, buy, hold, and sell ratings by Swayampakula Ramakanth.RatingPercentageCount Strong Buy0.7%3 ratings Buy93.9%430 ratings Hold5.5%25 ratings Sell0.0%0 ratingsOut of 458 total stock ratings issued by Swayampakula Ramakanth at HC Wainwright, the majority (93.9%) have been Buy recommendations, followed by 5.5% Hold and 0.7% Strong Buy.Best & Worst CallsBest Call000000.0%AEZSAug 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%HSGXMar 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ89.7% of companies on NASDAQ70 companiesNYSEAMERICAN3.8% of companies on NYSEAMERICAN3 companiesNYSE2.6% of companies on NYSE2 companiesOTCMKTS2.6% of companies on OTCMKTS2 companiesTSE1.3% of companies on TSE1 companySwayampakula Ramakanth, an analyst at HC Wainwright, currently covers 78 companies listed on NASDAQ, NYSEAMERICAN, NYSE, OTCMKTS and TSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical72 companies92.3%Manufacturing4 companies5.1%Computer and Technology2 companies2.6%Swayampakula Ramakanth of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE35 companies44.9%PHARMACEUTICAL PREPARATIONS10 companies12.8%MED - DRUGS9 companies11.5%MED INSTRUMENTS6 companies7.7%MEDICAL INFO SYS3 companies3.8%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES2 companies2.6%BIOTECHNOLOGY2 companies2.6%MED PRODUCTS2 companies2.6%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES1 company1.3%INTERNET SOFTWARE1 company1.3%MED - GENERIC DRG1 company1.3%MED - HMO1 company1.3%ELEC COMP - SEMIC1 company1.3%LABORATORY APPARATUS & FURNITURE1 company1.3%SURGICAL APPLIANCES & SUPPLIES1 company1.3%LARGE CAP PHARMA1 company1.3%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company1.3% About Swayampakula RamakanthDr. Ramakanth is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on the healthcare sector. Dr. Ramakanth’s research covers companies operating in oncology, wound health, medical devices, spine health and animal health. Dr. Ramakanth possesses over ten years of experience as a Life Sciences Equity Analyst as well as seven years of biotechnology industry experience. Prior to joining H.C. Wainwright, Dr. Ramakanth worked as a Junior Analyst at both Jefferies and Merrill Lynch covering large cap pharmaceuticals. Dr. Ramakanth was also a Junior Analyst at both First Albany and Rodman & Renshaw where he focused on biotechnology companies. Dr. Ramakanth also conducted bench research and directed a preclinical drug development group at Regeneron Pharmaceuticals, Inc. Dr. Ramakanth presented at various regional and international conferences and published in several peer-reviewed journals. Dr. Ramakanth’s educational background includes a Ph.D. in Pharmacology/Toxicology from the University of Utah, an MBA from Rutgers University, an M.S. in Pharmaceutics from Auburn University, and a B. Pharm (Hons.) from BITS, India. Dr. Ramakanth also held a post-doctoral fellowship at the University of Texas MD Anderson Cancer Center.Follow on LinkedIn Swayampakula Ramakanth's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCNXUConexeu Sciences6/22/2026Initiated Coverage$13.28$20.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals6/15/2026Reiterated Rating$99.35Buy$0.0000.00% ROIHUMAHumacyte6/11/2026Boost Price Target$1.04$4.00Buy$0.0000.00% ROIACTUActuate Therapeutics6/10/2026Reiterated Rating$2.01Buy$0.0000.00% ROINUVLNuvalent6/9/2026Downgrade$122.82$124.00Neutral$0.0000.00% ROIINABIN8bio6/4/2026Reiterated Rating$1.54Buy$0.0000.00% ROICELCCelcuity6/3/2026Lower Price Target$91.42$145.00Buy$0.0000.00% ROICORTCorcept Therapeutics6/2/2026Boost Price Target$70.44$95.00Buy$0.0000.00% ROIMDWDMediWound5/28/2026Reiterated Rating$14.33$36.00Buy$0.0000.00% ROICORTCorcept Therapeutics5/28/2026Boost Price Target$66.65$95.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. PGENPrecigen5/28/2026Boost Price Target$4.40$14.00Buy$0.0000.00% ROIHUMAHumacyte5/26/2026Reiterated Rating$1.09$3.00Buy$0.0000.00% ROIHYFTMindWalk5/19/2026Reiterated Rating$1.24$5.00Buy$0.0000.00% ROICELCCelcuity5/18/2026Boost Price Target$137.68$185.00Buy$0.0000.00% ROICTXRCitius Pharmaceuticals5/18/2026Reiterated Rating$0.55$4.00Buy$0.0000.00% ROIVORVor Biopharma5/18/2026Reiterated Rating$14.31$31.00Buy$0.0000.00% ROIACTUActuate Therapeutics5/18/2026Reiterated Rating$2.43$15.00Buy$0.0000.00% ROIETONEton Pharmaceuticals5/15/2026Boost Price Target$29.40$57.00Buy$0.0000.00% ROIPGENPrecigen5/14/2026Boost Price Target$4.15$11.00Buy$0.0000.00% ROICANFCan-Fite BioPharma5/12/2026Set Price Target$3.36$5.00Buy$0.0000.00% ROIVCELVericel5/8/2026Reiterated Rating$35.13$64.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals5/7/2026Set Price Target$101.07$185.00$0.0000.00% ROIBSEMBioStem Technologies5/6/2026Upgrade$4.18Strong-Buy$0.0000.00% ROICORTCorcept Therapeutics5/4/2026Boost Price Target$51.42$75.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals5/4/2026Boost Price Target$108.37$175.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals4/27/2026Boost Price Target$93.03$150.00Buy$0.0000.00% ROIEVAXEvaxion A/S4/24/2026Reiterated Rating$4.25$16.00Buy$0.0000.00% ROIACTUActuate Therapeutics4/22/2026Reiterated Rating$2.27$15.00Buy$0.0000.00% ROINUVLNuvalent4/21/2026Reiterated Rating$108.24$155.00Buy$0.0000.00% ROIVORVor Biopharma4/15/2026Lower Price Target$15.87$31.00Buy$0.0000.00% ROIACTUActuate Therapeutics4/13/2026Lower Price Target$1.72$15.00Buy$0.0000.00% ROIFOCLFocalTherics4/9/2026Lower Price Target$3.32$10.00Buy$0.0000.00% ROIRNXTRenovoRx4/8/2026Reiterated Rating$0.94$3.00Buy$0.0000.00% ROIIPHAInnate Pharma4/7/2026Reiterated Rating$1.35$5.00Buy$0.0000.00% ROIPGENPrecigen3/26/2026Boost Price Target$3.10$10.00Buy$0.0000.00% ROIOCGNOcugen3/25/2026Boost Price Target$1.92$10.00Buy$0.0000.00% ROICORTCorcept Therapeutics3/25/2026Lower Price Target$40.78$60.00Buy$0.0000.00% ROIPYXSPyxis Oncology3/24/2026Reiterated Rating$1.42$7.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals3/23/2026Reiterated Rating$88.51$130.00Buy$0.0000.00% ROIETONEton Pharmaceuticals3/20/2026Boost Price Target$22.67$52.00Buy$0.0000.00% ROIBill Gates said this would never work. Then he wrote a $100M check. (Ad)Bill Gates spent a decade insisting this energy source couldn't supply more than 5% of global power. Then he toured a construction site in the Nevada desert and told Bloomberg he now believes it could reach 20%. He followed that reversal with a $100 million investment. Facebook's co-founder added $462 million. Tesla's co-founder and Norway's sovereign wealth fund also took positions. One company - 60 years of operating history, revenue approaching $1 billion - sits at the center of all of it, with a July 4th catalyst that locks in its competitive advantage for eight years.See the stock behind the 100 million dollar reversal right hereLFWDLifeward3/19/2026Boost Price Target$6.72$10.00Buy$0.0000.00% ROIINABIN8bio3/13/2026Reiterated Rating$1.91Buy$0.0000.00% ROIALXOALX Oncology3/10/2026Reiterated Rating$2.13$4.00Buy$0.0000.00% ROIEVAXEvaxion A/S3/9/2026Reiterated Rating$3.22$16.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics3/9/2026Boost Price Target$77.56$130.00Buy$0.0000.00% ROIETONEton Pharmaceuticals3/2/2026Boost Price Target$16.99$37.00Buy$0.0000.00% ROIVCELVericel2/27/2026Boost Price Target$36.13$64.00Buy$0.0000.00% ROICORTCorcept Therapeutics2/20/2026Lower Price Target$34.24$67.00Buy$0.0000.00% ROIVSTMVerastem2/4/2026Initiated Coverage$6.30$18.00Buy$0.0000.00% ROIECORelectroCore1/26/2026Lower Price Target$7.47$18.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals1/26/2026Boost Price Target$94.29$130.00Buy$0.0000.00% ROICORTCorcept Therapeutics1/22/2026Boost Price Target$41.47$105.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals1/13/2026Reiterated Rating$89.50$102.00Buy$0.0000.00% ROIDCTHDelcath Systems1/9/2026Reiterated Rating$10.45$30.00Buy$0.0000.00% ROICGENCompugen1/7/2026Initiated Coverage$1.55$4.00Buy$0.0000.00% ROICGENCompugen1/7/2026Initiated Coverage$1.72$4.00Buy$0.0000.00% ROICORTCorcept Therapeutics1/2/2026Lower Price Target$34.80$90.00Buy$0.0000.00% ROICHRNChronoScale Corporation Common Stock12/31/2025Downgrade$10.61Neutral$0.0000.00% ROIPYXSPyxis Oncology12/19/2025Boost Price Target$1.73$7.00Buy$0.0000.00% ROIABSIAbsci12/17/2025Boost Price Target$3.54$8.00Buy$0.0000.00% ROIJANXJanux Therapeutics12/2/2025Lower Price Target$33.99$45.00Buy$0.0000.00% ROIHUMAHumacyte12/1/2025Reiterated Rating$1.36$3.00Buy$0.0000.00% ROIJANXJanux Therapeutics11/25/2025Reiterated Rating$31.53$70.00Buy$0.0000.00% ROICORTCorcept Therapeutics11/25/2025Reiterated Rating$77.71$145.00Buy$0.0000.00% ROIMDWDMediWound11/21/2025Reiterated Rating$16.86$36.00Buy$0.0000.00% ROIACTUActuate Therapeutics11/19/2025Reiterated Rating$6.10$20.00Buy$0.0000.00% ROICHRNChronoScale Corporation Common Stock11/18/2025Set Price Target$4.18$6.00Buy$0.0000.00% ROILFWDLifeward11/18/2025Lower Price Target$7.14$54.00Buy$0.0000.00% ROICELCCelcuity11/17/2025Reiterated Rating$92.68$94.00Neutral$0.0000.00% ROINUVLNuvalent11/17/2025Boost Price Target$112.06$155.00Buy$0.0000.00% ROIPGENPrecigen11/14/2025Boost Price Target$3.86$9.00Buy$0.0000.00% ROIVORVor Biopharma11/14/2025Lower Price Target$9.75$32.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics11/10/2025Boost Price Target$36.28$47.00Buy$0.0000.00% ROIPSNLPersonalis11/6/2025Boost Price Target$7.66$10.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals11/5/2025Boost Price Target$70.97$81.00Buy$0.0000.00% ROICANFCan-Fite BioPharma11/4/2025Reiterated Rating$8.24$50.00Buy$0.0000.00% ROIUNCYUnicycive Therapeutics10/29/2025Reiterated Rating$4.72$22.00Buy$0.0000.00% ROIIPHAInnate Pharma10/29/2025Set Price Target$2.10$5.00Buy$0.0000.00% ROIVORVor Biopharma10/29/2025Boost Price Target$25.28$52.00Buy$0.0000.00% ROIIPHAInnate Pharma10/29/2025Upgrade$2.00Strong-Buy$0.0000.00% ROIDYAIDyadic International10/23/2025Initiated Coverage$1.10$3.00Buy$0.0000.00% ROICELCCelcuity10/22/2025Boost Price Target$65.50$77.00Buy$0.0000.00% ROIVSTMVerastem10/21/2025Reiterated Rating$8.02$14.00Buy$0.0000.00% ROIDCTHDelcath Systems10/20/2025Set Price Target$11.42$30.00Buy$0.0000.00% ROIEVAXEvaxion A/S10/20/2025Reiterated Rating$6.79$16.00Buy$0.0000.00% ROICORTCorcept Therapeutics10/20/2025Reiterated Rating$79.49$145.00Buy$0.0000.00% ROICORTCorcept Therapeutics10/10/2025Reiterated Rating$88.36$145.00Buy$0.0000.00% ROIEVAXEvaxion A/S9/25/2025Boost Price Target$4.00$16.00Buy$0.0000.00% ROIACTUActuate Therapeutics9/23/2025Reiterated Rating$7.09$20.00Buy$0.0000.00% ROIIPHAInnate Pharma9/18/2025Downgrade$2.05Neutral$0.0000.00% ROIFour winners over 400%. Here's #5 (Ad)CFA and CMT analyst Garrett Goggin called G2 Goldfields before it rose 1,023%, Reunion Gold before 538%, Highlander Silver before 741%, and Orogen Royalty before 416%. He also publicly predicted Newmont's 126% gain in 2025. Now Goggin says the 1974 petrodollar agreement between Washington and Riyadh has quietly expired, central banks are buying gold at the fastest pace since 1950, and a major monetary shift is underway. He has identified four specific positions - plus two bonus opportunities for readers.Read the full briefing and see all four positions plus two bonusesPSNLPersonalis9/8/2025Reiterated Rating$5.24$8.50Buy$0.0000.00% ROIDNTHDianthus Therapeutics9/8/2025Reiterated Rating$26.50$40.00Buy$0.0000.00% ROICLGNCollPlant Biotechnologies8/21/2025Reiterated Rating$1.97$11.00Buy$0.0000.00% ROIPGENPrecigen8/19/2025Reiterated Rating$2.95$8.50Buy$0.0000.00% ROIPYXSPyxis Oncology8/19/2025Reiterated Rating$1.24$5.00Buy$0.0000.00% ROICELCCelcuity8/18/2025Boost Price Target$51.79$66.00Buy$0.0000.00% ROIACTUActuate Therapeutics8/18/2025Reiterated Rating$8.12$20.00Buy$0.0000.00% ROIAEMDAethlon Medical8/14/2025Reiterated Rating$1.23Neutral$0.0000.00% ROIVORVor Biopharma8/14/2025Reiterated Rating$40.40$60.00Buy$0.0000.00% ROIXFORX4 Pharmaceuticals8/13/2025Set Price Target$2.58$3.50Buy$0.0000.00% ROIPGENPrecigen8/13/2025Reiterated Rating$1.80$6.00Buy$0.0000.00% ROIHUMAHumacyte8/12/2025Lower Price Target$1.75$3.00Buy$0.0000.00% ROIMIRMMirum Pharmaceuticals8/7/2025Boost Price Target$53.39$80.00Buy$0.0000.00% ROIDCTHDelcath Systems8/7/2025Boost Price Target$10.64$31.00Buy$0.0000.00% ROIPSNLPersonalis8/6/2025Lower Price Target$5.64$8.50Buy$0.0000.00% ROICELCCelcuity7/28/2025Boost Price Target$39.34$50.00Buy$0.0000.00% ROIAEMDAethlon Medical7/7/2025Upgrade$1.27Neutral$0.0000.00% ROIOCGNOcugen6/24/2025Reiterated Rating$0.98$7.00Buy$0.0000.00% ROIELEVElevation Oncology6/10/2025Downgrade$0.38Neutral$0.0000.00% ROIETONEton Pharmaceuticals5/29/2025Reiterated Rating$20.08$35.00Buy$00.0000.00% ROIUNCYUnicycive Therapeutics5/27/2025Upgrade$5.53$90.00Strong-Buy$0.0000.00% ROIDCTHDelcath Systems5/23/2025Reiterated Rating$16.15$29.00Buy$00.0000.00% ROIMDWDMediWound5/22/2025Set Price Target$19.89$31.00Buy$00.0000.00% ROIMIRMMirum Pharmaceuticals5/19/2025Reiterated Rating$45.01$73.00Buy$00.0000.00% ROICELCCelcuity5/19/2025Reiterated Rating$10.61$27.00Buy$000.0000.00% ROIPYXSPyxis Oncology5/19/2025Reiterated Rating$1.21$5.00Buy$0.0000.00% ROIQSIQuantum-Si5/19/2025Reiterated Rating$1.41$5.50Buy$0.0000.00% ROIAFMDAffimed5/14/2025Downgrade$0.11Neutral$0.0000.00% ROIITOSiTeos Therapeutics5/14/2025Downgrade$7.98Neutral$0.0000.00% ROIHUMAHumacyte5/14/2025Initiated Coverage$1.93$4.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics5/13/2025Reiterated Rating$20.08$40.00Buy$00.0000.00% ROIOCGNOcugen5/12/2025Lower Price Target$0.70$7.00Buy$0.0000.00% ROIVORVor Biopharma5/9/2025Reiterated Rating$0.16Neutral$00.0000.00% ROIALXOALX Oncology5/9/2025Lower Price Target$0.46$2.00Buy$0.0000.00% ROIPSNLPersonalis5/7/2025Boost Price Target$4.00$9.00Buy$0.0000.00% ROICORTCorcept Therapeutics5/6/2025Lower Price Target$73.94$145.00Buy$00.0000.00% ROICHRNChronoScale Corporation Common Stock5/6/2025Lower Price Target$7.15$60.00Buy$00.0000.00% ROIXFORX4 Pharmaceuticals5/2/2025Boost Price Target$3.75$7.00Buy$0.0000.00% ROIIPHAInnate Pharma4/24/2025Reiterated Rating$2.00$11.00Buy$0.0000.00% ROIIPAImmunoPrecise Antibodies4/11/2025Reiterated Rating$0.42$5.00Buy$0.0000.00% ROIEVAXEvaxion A/S4/2/2025Reiterated Rating$1.66$14.00Buy$0.0000.00% ROIMDAISpectral AI4/2/2025Reiterated Rating$1.20$3.50Buy$0.0000.00% ROICELCCelcuity4/1/2025Reiterated Rating$10.11$27.00Buy$000.0000.00% ROIIPAImmunoPrecise Antibodies3/31/2025Lower Price Target$0.39$5.00Buy$0.0000.00% ROICORTCorcept Therapeutics3/31/2025Boost Price Target$100.43$150.00Buy$00.0000.00% ROIIPHAInnate Pharma3/28/2025Reiterated Rating$1.97$11.50Buy$0.0000.00% ROIFOCLFocalTherics3/28/2025Reiterated Rating$2.22$19.00Buy$0.0000.00% ROIRNXTRenovoRx3/27/2025Initiated Coverage$1.02$3.00Buy$0.0000.00% ROIXFORX4 Pharmaceuticals3/27/2025Reiterated Rating$8.08$45.00Buy$0.0000.00% ROIVORVor Biopharma3/21/2025Lower Price Target$17.04$260.00Buy$00.0000.00% ROIQuick favor to ask you (Ad)Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $29.97 on his website. Inside, you'll find a 5-part trade framework designed to make every trade a safer one. This free offer won't last - the price goes back to $29.97 soon.Click here to claim your free copy before the offer endsELEVElevation Oncology3/21/2025Lower Price Target$0.28$1.00Buy$0.0000.00% ROIMDWDMediWound3/20/2025Reiterated Rating$18.28$25.00Buy$00.0000.00% ROIPGENPrecigen3/20/2025Reiterated Rating$1.79$6.00Buy$0.0000.00% ROIABSIAbsci3/19/2025Reiterated Rating$3.08$7.00Buy$0.0000.00% ROIPYXSPyxis Oncology3/19/2025Reiterated Rating$1.06$5.00Buy$0.0000.00% ROIETONEton Pharmaceuticals3/19/2025Reiterated Rating$14.68$33.00Buy$00.0000.00% ROIMDAISpectral AI3/18/2025Reiterated Rating$1.76$3.50Buy$0.0000.00% ROIACTUActuate Therapeutics3/17/2025Initiated Coverage$7.25$20.00Buy$0.0000.00% ROIIPAImmunoPrecise Antibodies3/14/2025Reiterated Rating$0.41$7.00Buy$0.0000.00% ROIINABIN8bio3/14/2025Lower Price Target$6.79$180.00Buy$0.0000.00% ROIECORelectroCore3/13/2025Reiterated Rating$13.00$25.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics3/12/2025Reiterated Rating$23.38$40.00Buy$00.0000.00% ROILFWDLifeward3/11/2025Reiterated Rating$15.72$156.00Buy$0.0000.00% ROIELEVElevation Oncology3/10/2025Reiterated Rating$0.51$6.00Buy$0.0000.00% ROIDCTHDelcath Systems3/7/2025Boost Price Target$13.22$24.00Buy$0.0000.00% ROIALXOALX Oncology3/7/2025Reiterated Rating$1.31$5.00Buy$0.0000.00% ROIOCGNOcugen3/6/2025Reiterated Rating$0.57$8.00Buy$0.0000.00% ROIITOSiTeos Therapeutics3/6/2025Reiterated Rating$7.26$46.00Buy$0.0000.00% ROICHRNChronoScale Corporation Common Stock3/4/2025Reiterated Rating$7.23$135.00Buy$00.0000.00% ROIJANXJanux Therapeutics3/3/2025Reiterated Rating$32.89$70.00Buy$00.0000.00% ROIPSNLPersonalis2/28/2025Reiterated Rating$4.24$8.00Buy$0.0000.00% ROIVCELVericel2/28/2025Reiterated Rating$49.62$60.00Buy$00.0000.00% ROICORTCorcept Therapeutics2/27/2025Reiterated Rating$63.37$115.00Buy$00.0000.00% ROIBCYCBicycle Therapeutics2/26/2025Reiterated Rating$11.10$33.00Buy$0.0000.00% ROIEVAXEvaxion A/S2/20/2025Reiterated Rating$2.55$14.00Buy$0.0000.00% ROILFWDLifeward2/20/2025Reiterated Rating$22.08$156.00Buy$0.0000.00% ROIOCGNOcugen2/13/2025Boost Price Target$0.66$8.00Buy$0.0000.00% ROIINABIN8bio2/12/2025Reiterated Rating$9.20$240.00Buy$0.0000.00% ROICORTCorcept Therapeutics2/7/2025Reiterated Rating$68.04$80.00Buy$00.0000.00% ROIXFORX4 Pharmaceuticals2/7/2025Reiterated Rating$16.50$45.00Buy$0.0000.00% ROIIPHAInnate Pharma2/6/2025Reiterated Rating$1.95$11.50Buy$0.0000.00% ROIEVAXEvaxion A/S2/3/2025Reiterated Rating$2.45$14.00Buy$0.0000.00% ROICYPHCypherpunk Technologies1/29/2025Downgrade$0.65Neutral$0.0000.00% ROIPSNLPersonalis1/27/2025Lower Price Target$6.12$8.00Buy$00.0000.00% ROIALXOALX Oncology1/24/2025Lower Price Target$1.63$5.00Buy$0.0000.00% ROIPGENPrecigen1/23/2025Reiterated Rating$1.13$6.00Buy$0.0000.00% ROIETONEton Pharmaceuticals1/23/2025Boost Price Target$15.77$33.00Buy$00.0000.00% ROIIPHAInnate Pharma1/17/2025Reiterated Rating$1.67$11.50Buy$0.0000.00% ROIABSIAbsci1/17/2025Reiterated Rating$2.80$7.00Buy$0.0000.00% ROICYPHCypherpunk Technologies1/16/2025Reiterated Rating$3.25$5.50Buy$0.0000.00% ROIITOSiTeos Therapeutics1/16/2025Reiterated Rating$7.77$21.00Buy$0.0000.00% ROIVCELVericel1/15/2025Reiterated Rating$58.67$60.00Buy$00.0000.00% ROIQSIQuantum-Si1/14/2025Reiterated Rating$1.93$5.50Buy$0.0000.00% ROIELEVElevation Oncology1/14/2025Reiterated Rating$0.72$6.00Buy$0.0000.00% ROICHRNChronoScale Corporation Common Stock1/14/2025Reiterated Rating$10.68$135.00Buy$0.0000.00% ROIXFORX4 Pharmaceuticals1/14/2025Reiterated Rating$16.96$45.00Buy$0.0000.00% ROIDCTHDelcath Systems1/14/2025Reiterated Rating$12.79$22.00Buy$00.0000.00% ROIBCYCBicycle Therapeutics1/13/2025Reiterated Rating$14.68$33.00Buy$0.0000.00% ROIOCGNOcugen1/13/2025Reiterated Rating$0.75$7.00Buy$0.0000.00% ROIMDWDMediWound1/10/2025Reiterated Rating$16.01$25.00Buy$00.0000.00% ROIMy feud with Zohran Mamdani (Ad)Nearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson says what's unfolding in New York City is just the beginning. Tilson, a Harvard MBA who spent 30 years on Wall Street, has identified a specific economic pattern he believes points to a financial reset unlike anything seen in over 100 years. He's released a free analysis outlining what's coming and the exact steps he recommends you take with your money now.Read Whitney Tilson's free analysis and protect your wealth todayABSIAbsci1/8/2025Reiterated Rating$3.27$7.00Buy$0.0000.00% ROICORTCorcept Therapeutics10/18/2024Boost Price Target$47.17$80.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenThe Goldman Sachs GroupBMO Capital MarketsKeyCorpRoth MkmUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.